Nanoparticle

Vivacelle Bio Integrates Sub-Saharan Africa Strategy into Series B Financing Round

Retrieved on: 
Thursday, February 22, 2024
Blood pressure, Blood, School, Sepsis, Woman, IIA, Bleeding, Doctor of Philosophy, Resuscitation, The, Shock, MD, Diarrhea, Temperature, Septic, University, Nitric oxide, Shock (mechanics), Senior advisor, Finger, Life, Urinary tract infection, Risk, Internal bleeding, Pelvic floor dysfunction, Malaria, Hypovolemia, Nanoparticle, Gangrene, Neonatal sepsis, JD, Patient, Septic shock, Clinical trial, UMKC, Child, Reperfusion injury, Hypotension, Partnership

Targeted $20M Series B Round to include Sub-Saharan Africa in product development.

Key Points: 
  • Targeted $20M Series B Round to include Sub-Saharan Africa in product development.
  • Vivacelle Bio is partnering with Propelevate to drive the Sub-Saharan Africa strategy, which is fully integrated into its Series B financing round.
  • Through partnership with Propelevate, Vivacelle Bio will engage global health funders and stakeholders during final stages of product development, and Propelevate will drive Vivacelle Bio's go-to-market strategy for African markets upon regulatory approval.
  • "We are excited to partner with Vivacelle Bio because of their commitment to Sub-Saharan Africa.

EVŌQ Nano Announces That Its Antimicrobial Medical Device Platform Demonstrates Success Against the Leading Cause of Healthcare-Associated Infections

Retrieved on: 
Thursday, February 22, 2024
Nano, Infection, Catheter, Cell wall, Life, Fungal infection, Nanoparticle, Disease, Silver, Mortality, Antibiotics

SALT LAKE CITY, Feb. 22, 2024 /PRNewswire/ -- EVŌQ Nano, a nanoscience company that engineers novel nanoparticles for the life, material, and textile science industries, today announced its antimicrobial medical device platform has demonstrated effectiveness against the world's leading pathogens implicated in healthcare-associated infections (HAIs), which are some of the most common complications of hospital care.

Key Points: 
  • Our nanoparticle technology represents an exciting innovation that could profoundly reduce infections associated with medical devices like catheters without contributing to antibiotic resistance," said Shaun Rothwell, CEO of EVŌQ Nano.
  • By infusing EVŌQ Nano's proprietary nanoparticle, EVQ-218, throughout the polymer itself, medical devices are extrinsically equipped with antimicrobial protection that has proven to be effective against the most prevalent pathogenic microorganisms.
  • EVQ-218 delivers high antimicrobial efficacy without ion emissions.6,7 Its efficacy is rooted in EVQ-218's ability to disrupt bacteria's metabolic processes without triggering antimicrobial resistance.
  • By incorporating antimicrobial protection into the material manufacturing process, EVŌQ Nano's technology enables the next generation of medical devices to more effectively guard against disease.

Global Platinum Powder Market to Attain Revenue of $84.4 Million by 2030, Propelled by Rising Demand Across Diverse Industrial Sectors, States Kings Research

Retrieved on: 
Monday, February 12, 2024
Oxygen, USD, Platinum, Investment, Transport, Growth, Hydrogen, Conference, Microparticle, Perception, Attention, Nanoparticle, Particle size, Research report, Jewellery, Electricity, Role, PGI, Water, Palladium

On the basis of purity, the market is divided into high purity and standard purity.

Key Points: 
  • On the basis of purity, the market is divided into high purity and standard purity.
  • The high purity segment is projected to account for the largest share of the platinum powder market by the end of the forecast period, reaching a valuation of USD 59.17 million by 2030.
  • The demand for high purity platinum powder is anticipated to witness a surge owing to its exceptional suitability for crucial applications, which, in turn, guarantees consistent and trustworthy performance.
  • Purchase This Comprehensive Research Report for Valuable Market Insights: https://www.kingsresearch.com/buy-now/340
    The market for platinum powder is witnessing significant growth due to the increasing use of hydrogen fuel cell technology.

Global Platinum Powder Market to Attain Revenue of $84.4 Million by 2030, Propelled by Rising Demand Across Diverse Industrial Sectors, States Kings Research

Retrieved on: 
Monday, February 12, 2024
Oxygen, USD, Platinum, Investment, Transport, Growth, Hydrogen, Conference, Microparticle, Perception, Attention, Nanoparticle, Particle size, Research report, Jewellery, Electricity, Role, PGI, Water, Palladium

On the basis of purity, the market is divided into high purity and standard purity.

Key Points: 
  • On the basis of purity, the market is divided into high purity and standard purity.
  • The high purity segment is projected to account for the largest share of the platinum powder market by the end of the forecast period, reaching a valuation of USD 59.17 million by 2030.
  • The demand for high purity platinum powder is anticipated to witness a surge owing to its exceptional suitability for crucial applications, which, in turn, guarantees consistent and trustworthy performance.
  • Purchase This Comprehensive Research Report for Valuable Market Insights: https://www.kingsresearch.com/buy-now/340
    The market for platinum powder is witnessing significant growth due to the increasing use of hydrogen fuel cell technology.

Sail Biomedicines Appoints Kerry Benenato, Ph.D., as Chief Platform Officer

Retrieved on: 
Wednesday, February 7, 2024
Technology, Genetics, Health Technology, Software, Other Health, Biotechnology, Pharmaceutical, Health, Data Management, Artificial Intelligence, COVID-19, Growth, Biomedicine, RNA, Research, Harvard University, AI, Providence College, Platform, Nanoparticle, Flagship Pioneering, Messenger, MBA, National Institutes of Health, AstraZeneca, LNP, Endless, Bangladesh Technical Education Board, Infection, Management

Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Kerry Benenato, Ph.D., has been appointed to the position of the role of Chief Platform Officer, replacing Stuart Milstein, Ph.D., who is leaving the company to pursue other opportunities.

Key Points: 
  • Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Kerry Benenato, Ph.D., has been appointed to the position of the role of Chief Platform Officer, replacing Stuart Milstein, Ph.D., who is leaving the company to pursue other opportunities.
  • Dr. Benenato brings to Sail a storied career in the development of mRNA products and product candidates.
  • “We are delighted to welcome Kerry to Sail and its Executive Leadership Team.
  • “The potential of Sail’s platform – combining industry-leading Endless RNA™ (eRNA™) technology with uniquely programmable deployment nanoparticles, accelerated by AI – is unparalleled within the biopharma industry.

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery

Retrieved on: 
Tuesday, February 6, 2024
Marker beacon, Manuscript, Bioinformatics, Peptide, Weill Cornell Medicine, Research, Genetic variation, Nature Communications, Cardiovascular disease, Gene, Nanoparticle, Proteome, Metabolomics, GIP, Drug discovery, Mass spectrometry, Protein, Medicine, Biophysics, Proteomics, Physiology, Plasma

REDWOOD CITY, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a publication in Nature Communications from a study led by Weill Cornell Medicine showing Seer’s Proteograph workflow to potentially unveil novel proteogenomic insights into genetics-based drug and biomarker discovery for precision medicines. Designed to address the challenges with affinity-based proteomic approaches for protein quantitative trait loci (pQTL) studies, the scalable, high-resolution Proteograph workflow enables scientists to link genetic variation with protein abundance with peptide level resolution.

Key Points: 
  • The study found 184 PAVs in 137 genes, confirmed by their variant peptides in mass spectrometry data, known as MS-PAV.
  • Most MS-PAVs were aligned with known genetic markers (cis-pQTLs), validating the target specificity of the method.
  • Seer's approach provides customers with unparalleled insights into drug response analysis, drug discovery, patient stratifications for clinical studies, and precision medicine.
  • “At Seer, we offer researchers a new method for pQTL mapping and a deeper understanding of proteins and peptides for large-scale proteogenomic studies.”

SunHydrogen and COTEC of South Korea Advance to Next Phase of Production for 1m² Green Hydrogen Panels

Retrieved on: 
Monday, February 5, 2024
Oxygen, Consultant, OTCQB, Sunlight, Nanoparticle, University of Iowa, Hydrogen, MSC, University of Michigan, Water, University, Electricity

CORALVILLE, IA, Feb. 05, 2024 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTCQB: HYSR), the developer of a breakthrough technology to produce renewable green hydrogen using sunlight and water, today announced that the Company has initiated the scale-up phase for production of 1m² green hydrogen panels with its industrial partner, COTEC .

Key Points: 
  • CORALVILLE, IA, Feb. 05, 2024 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTCQB: HYSR), the developer of a breakthrough technology to produce renewable green hydrogen using sunlight and water, today announced that the Company has initiated the scale-up phase for production of 1m² green hydrogen panels with its industrial partner, COTEC .
  • SunHydrogen’s technology is currently the only self-contained nanoparticle-based hydrogen generation device capable of splitting water molecules into high-purity green hydrogen and oxygen using solely the sun’s energy.
  • Just like a solar panel is comprised of multiple cells that generate electricity, the Company’s hydrogen panel encases multiple hydrogen generators immersed in water.
  • “With the successful completion of COTEC’s initial exploration phase, we're excited to announce the next phase of scaling SunHydrogen’s generators for 1m² green hydrogen panels,” said SunHydrogen’s Chief Scientific Officer Dr. Syed Mubeen.

GIST Researchers Showcase New Breakthroughs for Unlocking the Potential of Plasmonics

Retrieved on: 
Wednesday, January 31, 2024
Advanced Optical Materials, Nanostructure, Magnesium, Research, Orientation, Sunlight, Nanoparticle, Environment, Light, GIST, Human body, Skin, Personal computer, Doctor of Philosophy, Optical phenomena, Assistant, Wound healing, Rotation, Advanced Materials, Seed

In this regard, "shadow growth" is a technique that utilizes vacuum deposition to produce nanoparticles from a wide range of 2D and 3D shapes in nanoscale.

Key Points: 
  • In this regard, "shadow growth" is a technique that utilizes vacuum deposition to produce nanoparticles from a wide range of 2D and 3D shapes in nanoscale.
  • Recent research progress in controlling this shadow effect has broadened the possibilities for the creation of different nanostructures.
  • This formation depends on the size of the seed, spacing between the seeds, and the inclination of the substrate."
  • These structures exhibit tunable optical properties achieved through suitable modifications to their material, shape, and surrounding environment.

Biosensors and Nanosensors Propel Towards a $43.5 Billion Global Market by 2028 - BCC Research Analysis Unveiled

Retrieved on: 
Wednesday, January 31, 2024
Wearable, Nanotechnology, Microfluidics, Growth, Internet of things, Research, Nanoparticle, Miniaturization, International finance, Nanosensor, Nano, Environmental monitoring, Integration, Sensor, Biosensor, Nanocomposite, Heart rate, Algorithm, BCC, Artificial intelligence, Geography, Health, Market, Medical imaging

BOSTON, Jan. 31, 2024 /PRNewswire/ -- Biosensors and nanosensors represent cutting-edge technologies that have significantly advanced the landscape of global markets. Biosensors are analytical devices that combine biological components with sensors to detect and quantify specific substances, offering applications in healthcare, environmental monitoring, and more. Nanosensors, operating at the nanoscale, leverage nanotechnology to enhance precision and sensitivity in detecting various analytes. The global market for these technologies is characterized by rapid advancements, fueled by innovations in nanotechnology, IoT integration, and miniaturization. These sensors find extensive application in healthcare diagnostics, environmental monitoring, and various industries. This report delves into the dynamic market trends and technologies shaping the biosensors and nanosensors arena, providing valuable insights into the transformative potential of these innovations on a global scale.

Key Points: 
  • The global market for these technologies is characterized by rapid advancements, fueled by innovations in nanotechnology, IoT integration, and miniaturization.
  • "According to the latest BCC Research study, the demand for Biosensors and Nanosensors: Global Markets and Technologies is estimated to increase from $30.6.0 billion in 2023 to reach $43.5 billion by 2028, at a compound annual growth rate (CAGR) of 7.3% from 2023 through 2028."
  • This comprehensive report delves into the intricate details of the worldwide biosensors and nanosensors market, providing a meticulous analysis categorized by product type, technology, application, and geography.
  • The narrative elucidates the primary drivers propelling the global biosensors and nanosensors market, coupled with regional dynamics and prevailing industry trends.

A faster, more efficient imaging system for nanoparticles

Retrieved on: 
Tuesday, January 30, 2024
Nanoparticle, Research, Nanomedicine, Temperature, Photon, Science, Tissue, Cancer, SWIR, Advanced Science, Noetics, INRS, Doctor of Philosophy, Metabolism, Cell, Medical imaging

A new technique developed at INRS pushes back some of the limits of the infrared imaging of rare-earth doped nanoparticles.

Key Points: 
  • A new technique developed at INRS pushes back some of the limits of the infrared imaging of rare-earth doped nanoparticles.
  • It consists of a high-precision, short-wave infrared imaging technique capable of capturing the photoluminescence lifetimes of rare-earth doped nanoparticles in the micro- to millisecond range.
  • What's more, the photoluminescence lifetime of nanoparticles doped with these ions has the advantage of being minimally affected by external conditions.
  • Finally, in fundamental science, these unprecedented results will allow scientists to synthesize rare-earth nanoparticles with even more interesting optical properties.